Bullseyebob, I think I said after Ropren's success has been proven for some time in the marketplace then big pharmaceutical companies might be interested in taking SLA over. As an example Pfizer recently aborted their new cholesterol lowering drug when it was very close to launch. I sent them the trial results information on Bioeffective R and they sent back a note thanking me and saying they would pass it onto their R&D department.
As for the price I have no idea but I do know it will be many multiples of the current level.
SLA Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held
